MedPath

Metacognitive Therapy for Comorbid Insomnia

Not Applicable
Withdrawn
Conditions
Secondary Insomnia
Interventions
Behavioral: meta-cognitive therapy
Other: waiting list
Registration Number
NCT00235365
Lead Sponsor
Norwegian University of Science and Technology
Brief Summary

The purpose of this study is to determine the effect of meta-cognitive therapy for insomnia.

Detailed Description

This study is a randomized controlled trial with 50 patients with a psychiatric disorder and insomnia. The patients will be randomized into two groups of 25 patients. The first group receives meta-cognitive therapy, whereas the second group will be assigned to a waiting list control.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Insomnia secondary to a primary psychiatric disorder
Exclusion Criteria
  • substance abuse, psychotic symptoms, suicidal intentions, severe organic disorder or psychiatric disorder where sleep restriction is not advised, organic sleep disorder.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
meta-cognitive therapymeta-cognitive therapymeta-cognitive therapy
waiting listwaiting listwaiting list control
Primary Outcome Measures
NameTimeMethod
Scores on rating scales for sleep qualityone year
Secondary Outcome Measures
NameTimeMethod
Scores on rating scales for depression, psychiatric symptom severity, and cognitive processing.one year
© Copyright 2025. All Rights Reserved by MedPath